We found that patients with high NEK2 and TUFT1 expression had a significantly high rate of lymph node metastasis (Fig. 7E and Table S1), reflecting poor outcome. This evidence concerns the gene TUFT1 and metastatic malignant neoplasm in the lymph nodes.